01:35 PM EDT, 09/10/2024 (MT Newswires) -- AbbVie ( ABBV ) said Tuesday that Health Canada has approved Constella, or linaclotide, for the treatment of functional constipation in patients between six and 17 years old. The approval is based on results from a phase 3 study that showed Constella increased the frequency of spontaneous bowel movements in this patient population,...

01:37 PM EDT, 09/10/2024 (MT Newswires) -- Nike ( NKE ) shareholders on Tuesday voted against proposals requiring the company to reassess working conditions at sourcing locations and its supply chain, according to media reports Tuesday. One proposal would require the company to publish a report assessing how the implementation of worker-driven social responsibility principles and support of binding agreements...

01:37 PM EDT, 09/10/2024 (MT Newswires) -- (Updates with additional details from the second paragraph.) Teva Pharmaceutical Industries ( TEVA ) is expected to face a fine by the European Union antitrust watchdog for being dismissive of a rival multiple sclerosis product competing with Copaxone, multiple sources reported Tuesday, citing people aware of the situation. In 2022, the European Commission...

01:38 PM EDT, 09/10/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Tuesday that efsitora lowered blood sugar in certain adults with type 1 and 2 diabetes in separate phase 3 trials. The QWINT-2 study compared once-weekly insulin efsitora alfa to once-daily insulin degludec in adults with type 2 diabetes who are new to insulin. Data show efsitora reduced...